Dr. Peter Silverstone on the Science of Psychedelic Therapy

The Ingenium Books Podcast: Author. Publisher. Changemaker.

Dr. Peter Silverstone's quest to revolutionize mental health treatment took an unexpected turn when he stumbled upon a shocking discovery. The implications are mind-blowing, and the future of mental health therapy may never be the same. But what did he find?

There is real potential, there is real hope, there is real optimism.

Our special guest is Dr. Peter Silverstone

Meet Dr. Peter Silverstone, an accomplished psychiatrist, researcher, and scientist who specializes in the potential applications of psychedelic-assisted psychotherapy for severe mental health disorders. Dr. Silverstone's expertise in this field is showcased in his Wall Street Journal bestselling book, "The Promise of Psychedelics: Science-Based Hope for Better Mental Health."

There was a time when Dr. Peter Silverstone found himself perplexed by the staggering number of people affected by mental health disorders worldwide. As a dedicated physician, he wanted to explore new avenues for helping those who didn’t respond to traditional treatments. Dr. Silverstone's curiosity led him to investigate the potential of psychedelic-assisted psychotherapy for severe mental health disorders, an area shrouded in controversy and taboo.
Ranking Psychedelics
As research into the potential benefits of psychedelic substances for mental health treatment continues, a number of substances have shown promise in this field. Sorting and categorizing these psychedelics by their clinical usefulness can help professionals better understand their capabilities and applications in therapeutic settings.
Dr. Peter Silverstone shares his perspective on ranking psychedelics during his conversation with Boni Wagner-Stafford on The Ingenium Books Podcast. Dr. Silverstone considers psilocybin, ketamine, and MDMA to be the most promising candidates for prescription use in limited cases. By organizing and discussing these substances in his book, he provides valuable information for understanding the potential uses, limitations, and risks of psychedelic therapy.

In this episode, you will be able to:

• Discover the promising effects of psychedelic-assisted psychotherapy on serious mental health disorders.
• Uncover the innovative almond therapy approach, specifically designed for the amygdala.
• Learn how to classify psychedelics based on their clinical value in mental health treatment.
• Explore the hurdles Dr. Silverston'e company, Zylorion Health, encounters in mental health research and development.
• Recognize the importance of funding and investment in personalized mental health treatment.

Support the show

Thanks for listening! Find us wherever you get your podcasts. Subscribe to our YouTube Channel (@ingeniumbooks) or visit our website at ingeniumbooks.com.

· https://ingeniumbookspodcast.com
· https://www.linkedin.com/company/ingeniumbooks/
· https://ingeniumbooks.com
· https://www.facebook.com/ingeniumbooks
· https://www.youtube.com/@ingeniumbooks
· https://www.twitter.com/ingeniumbooks
· https://instagram.com/ingeniumbooks